One significant area of concern is the corneal endothelium, which plays a crucial role in maintaining corneal transparency and overall eye health. Recent research has focused on understanding how ...

In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal endothelial disease.

Descemet's stripping automated endothelial keratoplasty (DSAEK) is the gold standard for the surgical treatment of corneal endothelial diseases. Following its introduction over the last decade ...

Cell therapy company Aurion Biotech is moving forward with plans to IPO despite a pending lawsuit from one of its existing ...

AS-OCT improves surgical results in femtosecond laser-assisted corneal surgery such as laser ... period in Descemet stripping automated endothelial keratoplasty cases. Ultra-high-resolution ...

The biotech IPO landscape gains momentum in 2025 as Aurion Biotech, Maze Therapeutics, and Metsera file for offerings. Aurion focuses on regenerative therapies, Maze advances precision medicines for ...